ProTreat: an adaptive and rapid implementation trial of novel therapies to prevent and treat COVID-19 infection in high risk cancer patients

  • Funded by Medical Research Future Fund (MRFF)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $3,935,388.68
  • Funder

    Medical Research Future Fund (MRFF)
  • Principal Investigator

    N/A

  • Research Location

    Australia
  • Lead Research Institution

    University of Melbourne
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

MRFF Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity research recipient